Your browser doesn't support javascript.
loading
An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response.
Wang, Ying-Nai; Lee, Heng-Huan; Wei, Yongkun; Chu, Yu-Yi; Xia, Weiya; Wang, Michael; Yu, Dihua; Hung, Mien-Chie.
Affiliation
  • Wang YN; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Lee HH; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wei Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Chu YY; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Xia W; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wang M; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Yu D; Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology, and Center for Molecular Medicine, China Medical University, Taichung 404, Taiwan.
  • Hung MC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
STAR Protoc ; 3(1): 101198, 2022 03 18.
Article in En | MEDLINE | ID: mdl-35243381

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: STAR Protoc Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: STAR Protoc Year: 2022 Type: Article Affiliation country: United States